Post-approval studies (Phase 4)Study completedNCT01147107
What this trial is testing
Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection
Who this might be right for
Hepatitis C, ChronicHIV Infection
University of Hawaii 80